Driving Innovation for
enhanced therapeutics
O2W_logo_final Sept 19 2022

Cannabinoid Delivery

The Next Generation Delivery System

O2W is a best-in-class Self-Microemulsifying Drug Delivery System (SMEDDS) that significantly enhances the solubility and bioavailability of cannabinoids.

Free of Polyethylene Glycols (PEGs), O2W improves the safety of cannabinoids by reducing the impact on the liver through enhanced lymphatic absorption.

Breakthrough Product Platforms

Customizable and Tunable for every need

O2W Concentrate

Water-free Concentrate
Formulation Platform

High-potency, fast-acting

O2W Powder

Microencapsulated Powder
Formulation Platform

Extra high-potency,

O2W Gel


Semi-solid FormulationPlatform

High-potency, extended-release


Our breakthrough, proprietary product platforms can be customized to produce an unmatched variety of dosage forms with tunable release profiles.

Unprecedented Performance

Fastest Oral bioavailability-enhancing formulation

O2W has an unprecedented onset of action, with the maximum concentration of CBD achieved at 20-30 min compared to unformulated CBD at 4-6 hours. This means that the effects will be felt in minutes, not hours.

O2W also demonstrated a substantial improvement of CBD bioavailability through a significant increase in area under curve (AUC) and Cmax, compared to control group.

O2W self-microemulsification under an electronic microscope.

Who Is Micellae

Micellae is an innovative technology-based company founded on 15 years of research at University of Toronto.

We aim to provide the most advanced Drug Delivery System to produce the highest performing pharmaceutical and medical products.

Partner With Us

Take your product to the next generation

Our experts will work with you every step of the way to find the best solution for your product.


U of T Logo
PEG is a broad name for a wide variety of products and is found...